Regenovate Technology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 50.00 K
as on 17-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -86.46%
(FY 2022)
- Profit 69.41%
(FY 2022)
- Ebitda 56.44%
(FY 2022)
- Net Worth 97.71%
(FY 2022)
- Total Assets %
(FY 2022)
About Regenovate Technology
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Rathan Basavegowda and Basave Gowda serve as directors at the Company.
- CIN/LLPIN
U72900KA2017PTC105940
- Company No.
105940
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Ramanagar, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Regenovate Technology Private Limited offer?
Regenovate Technology Private Limited offers a wide range of products and services, including Rapid Test Kit, Corona Test Kit.
Who are the key members and board of directors at Regenovate Technology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rathan Basavegowda  | Director | 29-Aug-2017 | Current |
| Basave Gowda | Director | 29-Aug-2017 | Current |
Financial Performance of Regenovate Technology.
Regenovate Technology Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 86.46% decrease. The company also saw a substantial improvement in profitability, with a 69.41% increase in profit. The company's net worth Soared by an impressive increase of 97.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regenovate Technology?
In 2018, Regenovate Technology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisave Health And Lifestyle Private LimitedActive 3 years 10 monthsRathan Basavegowda and Basave Gowda are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regenovate Technology?
Regenovate Technology has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regenovate Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenovate Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
